Yin Yang 1 contains G-quadruplex structures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase 1 by Huang, Weiwei et al.
Yin Yang 1 contains G-quadruplex structures
in its promoter and 50-UTR and its expression
is modulated by G4 resolvase 1
Weiwei Huang
1,2, Philip J. Smaldino
1, Qiang Zhang
1, Lance D. Miller
1, Paul Cao
1,
Kristin Stadelman
1, Meimei Wan
1, Banabihari Giri
1, Ming Lei
2, Yoshikuni Nagamine
3,
James P. Vaughn
1, Steven A. Akman
1 and Guangchao Sui
1,*
1Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of
Medicine, Winston-Salem, NC 27157, USA,
2Shaanxi Key Laboratory for Molecule Biology of Agriculture,
College of Life Sciences, Northwest A&F University, Yangling, 712100 Shaanxi Province, P. R. China and
3Friedrich Miescher Institute for Biomedical Research Norvartis Research Foundation, 4058 Basel, Switzerland
Received November 23, 2010; Revised September 21, 2011; Accepted September 22, 2011
ABSTRACT
Yin Yang 1 (YY1) is a multifunctional protein with
regulatory potential in tumorigenesis. Ample
studies demonstrated the activities of YY1 in
regulating gene expression and mediating differen-
tial protein modifications. However, the mech-
anisms underlying YY1 gene expression are
relatively understudied. G-quadruplexes (G4s) are
four-stranded structures or motifs formed by
guanine-rich DNA or RNA domains. The presence
of G4 structures in a gene promoter or the 50-UTR
of its mRNA can markedly affect its expression. In
this report, we provide strong evidence showing the
presence of G4 structures in the promoter and the
50-UTR of YY1. In reporter assays, mutations in
these G4 structure forming sequences increased
the expression of Gaussia luciferase (Gluc) down-
stream of either YY1 promoter or 50-UTR. We also
discovered that G4 Resolvase 1 (G4R1) enhanced
the Gluc expression mediated by the YY1
promoter, but not the YY1 50-UTR. Consistently,
G4R1 binds the G4 motif of the YY1 promoter
in vitro and ectopically expressed G4R1 increased
endogenous YY1 levels. In addition, the analysis of
a gene array data consisting of the breast cancer
samples of 258 patients also indicates a significant,
positive correlation between G4R1 and YY1
expression.
INTRODUCTION
Yin Yang 1 (YY1) is a multifunctional protein that is es-
sential to differential epigenetic regulation of gene expres-
sion and protein modiﬁcations. As a ubiquitously
expressed protein, YY1 acts as a transcription factor to
either activate or repress its target genes depending on the
context of its recruited cofactors (1–3). Structural and
functional studies indicate that YY1 uses distinct
domains to bind to target promoters and recruit transcrip-
tional cofactors to modulate gene expression (4). Many
YY1-interacting proteins possess activities of regulating
protein modiﬁcations. Therefore, YY1 potentially
mediates the modiﬁcations of a variety of histone and
non-histone proteins to determine the expression statuses
of its target genes. Consistently, YY1 has been reported to
regulate many genes whose products play essential roles in
cell proliferation and differentiation [reviewed in (2–5)].
Many lines of evidence suggest a regulatory role of YY1
in cancer development. YY1 is one of the polycomb group
(PcG) proteins that are essential contributors to the
aberrant epigenetics in cancers (6). At the transcriptional
level, YY1 regulates the expression of many cancer-related
genes, such as c-Myc, c-fos, erbb2, p53, Rb and cdc6
(7–12), as well as histones H3 and H4 (13,14). During
apoptosis, YY1 colocalizes with p53, binds to a subset
of p53 DNA-target sites and regulates p53-dependent
transcription (15). At the post-translational level, YY1 as-
sociates with many proteins with critical regulatory func-
tions, such as p300, HDAC1,2,3, Ezh1, Ezh2, PRMT1,
p53, Mdm2, p14ARF, Rb and mTOR (16–25). YY1 is
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H1-K26 and H3-K27) (20,26) and PRMT1 (on H4-R3)
(21). We and others demonstrated that YY1 negatively
regulates p53 through enhancing Mdm2-mediated p53
ubiquitination and degradation (22,27–29). YY1 also
blocks p300-mediated p53 acetylation (27) and inhibits
p53-activated transcription (15). Actually, blocking p53
acetylation can both decrease its transcriptional activity
(30–32) and facilitate Mdm2-mediated p53 ubiquitination
and degradation (33). Therefore, the activities of YY1 in
enhancing p53 ubiquitination and inhibiting p53 acetyl-
ation converge to the same consequence: antagonizing
p53. These multiple functions and unique properties
endow YY1 with a pivotal role in epigenetic regulation,
including genomic imprinting and chromatin remodeling.
Consistently, YY1 is highly expressed in human breast
cancer (9), prostate carcinoma (34), acute myeloid
leukemia (35), osteosarcoma (36,37) and cervical
cancer (38).
Limited research has been carried out to investigate the
mechanisms underlying how YY1 is regulated. YY1 gene
expression can be stimulated by different growth stimuli,
including insulin-like growth factor-1, ﬁbroblast growth
factor-2 and morphine. Factors that inhibit
YY1 expression include prohibitin, microRNA-29,
DETANONOate (a nitric oxide donor) and naloxone
[see review (3)]. YY1 may also self-regulate its own expres-
sion through binding to the intron 1 (39).
G-quadruplex (G4) is a four-stranded secondary struc-
ture of DNA or RNA stabilized by Hoogsteen hydrogen
bonding of guanine quartets and the stacking of these
planar quartets. A genome-wide survey of the evolution-
ary conservation of DNA motifs indicated that G4 DNA
motifs are signiﬁcantly conserved (40). Increasing evidence
suggests an important role of G4 DNA structures in
regulating gene expression (41). Interestingly, G4 DNA
structures are more enriched in promoters than other
regions of genomic DNA, especially in genes involved in
development, survival and proliferation.
Recent studies implicate a role for G4 DNA in tumori-
genesis. The telomeric G-rich DNA overhang forms G4
structures that inhibit the activity of telomerase required
for the immortalization of most cancer cells (42). The
majority of proto-oncogenes possess G-rich promoters,
while promoters of tumor suppressors are diminished
of closely linked G-runs, relative to the genomic average
(43). Consistently, G4 DNA structures have been
demonstrated to regulate the expression of a number of
well-characterized oncogenes, such as c-Myc, K-RAS,
Bcl-2 and hTERT. Actually, the six critical cellular and
microenvironmental processes that are aberrantly
regulated in oncogenic transformation, as summarized
by Hanahan and Weinberg (44), are all modulated by
genes that are regulated by G4 structures (40).
Several DNA and RNA helicases with the catalytic
activity to unwind or resolve G4 DNA or G4 RNA struc-
tures have been identiﬁed, including BLM, WRN,
FANCJ, G4R1 (or G4R1/RHAU, DHX36), RNA
helicase II (DHX9) and SV40 large T-antigen (45–47).
These G4 DNA or RNA resolvases can unwind the
four-stranded G4 structures to a single-stranded form in
an ATP-dependent fashion (48,49). Among them, G4R1
possesses tetramolecular and intramolecular quadruplex
G4 DNA and G4 RNA resolving activity (50–52).
Importantly, G4R1 has been observed to be increasingly
expressed in cancers (unpublished data from Akman
group), suggesting its regulatory role in promoting the
expression of oncogenes.
Based on previous studies of YY1 in differential
cancer-related processes, we concluded that YY1 likely
plays an oncogenic or proliferative role in tumorigenesis
(3). A previous study indicated that the promoter of
mouse YY1 is G/C rich (53). Therefore, we analyzed the
primary sequences at the upstream of the human YY1
coding region, and observed the presence of multiple G-
or C-rich strings. In this report, we demonstrate that G4
structures are formed by the oligonucleotides whose se-
quences are found in the promoter and 50-untranslated
region (UTR) of YY1. The alteration of these sequences
affects the expression of a reporter gene. G4R1 promotes
the expression driven by the YY1 promoter, but not that
mediated by the YY1 50-UTR. Consistently, ectopic G4R1
increases the endogenous YY1 levels and G4R1 expres-
sion positively correlates with YY1 in the samples from
258 breast cancer patients. Overall, our data reveal the
presence of G4 structures in the YY1 promoter and
50-UTR, and suggest that G4R1 may modulate YY1 ex-
pression by resolving G4 DNA structure in the YY1
promoter.
MATERIALS AND METHODS
Cell culture and transient transfection
HeLa and 293T cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium containing 10% fetal bovine serum.
Lipofectamine 2000 was used in transient transfection.
The HeLa cells expressing doxycycline-inducible G4R1
shRNA were reported previously (54) and the induction
was achieved by adding a ﬁnal concentration of 1.5mg/ml
doxycycline in the medium.
Antibodies and oligonucleotides
YY1 antibody (H-10), histone H3 antibody (FL-136) and
non-speciﬁc mouse IgG (sc-2343) were purchased from
Santa Cruz Biotechnology. Mouse monoclonal G4R1/
RHAU antibody (12F33) was generated against a
peptide corresponding to the amino acids 991–1007 of
G4R1, as previously described (55). b-Actin antibody
was from Chemicon International Inc. DNA oligonucleo-
tides or primers were synthesized by Bioneer Inc. and
Integrated DNA Technologies (IDT), while the RNA
oligonucleotides were made by the Biomolecular
Resource Laboratory, Wake Forest University School of
Medicine. The annealing condition for G4 structure for-
mation followed a published procedure (52) with modiﬁ-
cations (Supplementary Figure S1).
DNA vector construction
To generate reporter constructs driven by the YY1
promoter, the  1703 to  1 (with the transcription start
1034 Nucleic Acids Research, 2012,Vol.40, No. 3site designated as+1; this applies to all following descrip-
tions) of the YY1 promoter region was ampliﬁed by PCR
using AccuPrime Pfx DNA polymerase (Invitrogen) with
primers F1: ‘cctg gaattc att ggt gtt tat ggg gaa gta tca’ and
R1: ‘ctag tctaga ctc gat tct cct ctc ggc caa tc’ (F: forward;
R: reverse). The template was the clone RP11-459E8 con-
taining YY1 gene purchased from the BACPAC
Resources Center (Oakland, CA, USA). The PCR
fragment was digested by EcoRI and XbaI (underlined
in the primer sequences) and inserted into EcoRI and
NheI digested pGluc Basic (New England BioLabs Inc.),
of which the multiple cloning site has been modiﬁed. To
mutate the G4 structure-forming sequence between  409
and  347 in the negative strand of the YY1 promoter, we
synthesized two primers F2: ‘ccgtg gcatgc gcc tca acc tcg
ctc ccg gcc ggc ccc tc’ and R2: ‘ccgtg gcatgc gcg gcc cgg
ggg ccg cgc ggg gag’ containing a created SphI sites
(underlined) that facilitated the DNA subcloning and
altered the guanines essential to the predicted G4 structure
formation. They were respectively used with the ﬁrst two
primers (F1 with R2; F2 with R1) to amplify the YY1
promoter as two PCR fragments that were then digested
by the corresponding restriction enzymes and subcloned
simultaneously into the modiﬁed pGluc Basic vector. As a
result, the mutated form of the YY1 promoter containing
an altered G4 structure-forming sequence was generated.
To study the contribution of the G4 structure forming
sequence in the YY1 50-UTR to Gluc expression, we
ampliﬁed the YY1 50-UTR using primers F3: ‘cacg
acgcgt agg gcg aac ggg cga gtg gca g’ and R3: ‘cgag
ggatcc ggc tga ggg ctc cgc cgc cac g’ with the
RP11-459E8 plasmid as a template. After the digestion
of MluI and BamHI (underlined), the fragment was
inserted between the PGK promoter and Gluc cDNA of
a reporter construct. To mutate the G4 structure-forming
sequence in the YY1 50-UTR, we synthesized two add-
itional primers F4: ‘cgga ggtacc cgg gga agc ccc gcc gcc
gcc’ and R4: ‘cgga ggtacc tcg cct cgg tgc gcc cgc gcc’ that
both contain a created KpnI sites to facilitate the
subcloning and mutate the guanines essential to the pre-
dicted G4 structure formation. The PCR reactions using
these primers F3 with R4 and F4 with R3 ampliﬁed the
YY1 50-UTR into two fragments, which were then simul-
taneously subcloned into the pPGK-Gluc vector. The se-
quences of all wild-type and mutated reporter constructs
described here were conﬁrmed by DNA sequencing.
Circular dichroism study
To anneal G-quadruplexes, 20ml of 100pmol/ml DNA or
RNA oligonucleotides was mixed with 180ml of TE buffer
(10mM Tris–HCl, 0.1mM EDTA, pH 7.5) and annealed
as described in Supplementary Figure S1. These annealed
oligonucleotides were diluted to 4mM in the TE buffer
supplied with 50mM KCl. Circular dichroism (CD)
spectra were recorded on a spectropolarimeter (Aviv
Model 202 CD Spectrometer, equipped with a thermoelec-
trically controlled cell holder) using a quartz cell of
0.5mm optical path length, and over a wavelength range
from 200 to 350nm at 25 C. For melting temperature
scan, we used a temperature range from 20 Ct o9 5  C
with a constant wavelength of 262nm. The CD spectra
were presented with the subtraction of the signal
contributed by the buffer.
50-
32P-end labeling of G4 nucleic acids
To produce a 50-
32P-labeled G4 oligonucleotide, an
aliquot (<1/10 of the ﬁnal volume for the labeling
reaction) of the annealed G4 oligonucleotide was
incubated with T4 polynucleotide kinase (Promega
Corp.) and g-
32P-ATP for 30min at 37 C, according to
the manufacturer’s instructions. The 50-
32P-labeled G4
oligonucleotides were puriﬁed with a MicroSpin G25
column (GE Healthcare) equilibrated with TEK buffer
(10mM Tris, 1mM EDTA and 50mM KCl) and stored
at  20 C.
Dimethyl sulfate footprinting
Dimethyl sulfate (DMS) footprinting was carried out fol-
lowing a modiﬁed version of previously published proto-
cols (56,57). A puriﬁed 50-
32P-labeled oligonucleotide was
annealed in the absence and presence of 100mM KCl or
100mM LiCl, and 1mg/ml of sonicated salmon sperm
DNA. DMS (Sigma) dissolved in ethanol (DMS:ethanol,
4/1, v/v) was added to the oligonucleotide solution (0.7ml
to a total volume of 49ml) and incubated at room tem-
perature for 3min. The reaction was stopped by adding
two volumes of the stop solution (1.5M sodium acetate,
pH 7.0, 1.0M b-mercaptoethanol and 0.5mg/ml tRNA).
The DNA was precipitated with four volumes of ethanol
and resuspended in 1.0M piperidine (Sigma). After
cleavage at 95 C for 30min, the DNA was precipitated
by adding 20mg of glycogen (Invitrogen), one-ninth
volume of 3M sodium acetate (pH 5.2) and two
volumes of ethanol. For the Maxam-Gilbert chemical
G+A sequencing reaction, an oligonucleotide was
treated by formic acid and piperidine following a
standard protocol (58). The samples were resuspended in
90% formamide and 20mM EDTA, denatured at 95 C
for 3min and run for 2–3h on an 18% denaturing poly-
acrylamide gel (Bio-Rad) in 1  TBE and 8.0M urea.
After the electrophoresis, the gel was ﬁxed in a solution
containing 50% methanol and 10% polyethylene glycol
400, and dried at 80 C for 3h followed by
autoradiography.
In vitro DNase I footprinting of the YY1 promoter
regions
As previously demonstrated by Sun et al. (59,60), the G4
structures and i-motifs formed by G-rich and C-rich
regions, respectively, are resistant to DNase I cleavage.
The experiments followed the procedure described by
Sun (60). We ﬁrst subcloned a fragment ( 1180 to
 329) of the YY1 promoter into pGL3-Basic vector
(Promega) between HindIII and XhoI sites. The generated
vector pGL3/YY1-short-prmt included the G4 structure
forming or the YP-3 sequence ( 409 to  347). This
plasmid (2mgi n2 5 ml) was incubated at 37 C overnight
in 50mM Tris–HCl, pH 7.6 in the absence or presence of
100mM KCl. The sample was then mixed with 2mlo f
0.1U/ml DNase I and incubated at ambient temperature
Nucleic Acids Research,2012, Vol.40, No. 3 1035for 2min, immediately followed by DNA precipitation
and primer extension reaction using
32P-labeled primer
P1 (CTT TCT TTA TGT TTT TGG CGT CTT) located
downstream of the inserted YY1 promoter fragment and
Thermo Sequenase (Affymetrix Inc.). Meanwhile, the
G-rich negative strand of the YY1 promoter fragment in
the untreated plasmid was sequenced by the same primer
using Thermo Sequenase Cycle Sequencing Kit (Cat#
78500, Affymetrix Inc.) following the procedure
provided by the manufacturer. These samples were
resolved by a 6% denaturing polyacrylamide gel
(Bio-Rad) in 1  TBE and 8.0M urea at constant 55 W
for 3h. After the electrophoresis, the gel was dried at 80 C
for 2h followed by autoradiography.
Electrophoretic mobility shift assays
Recombinant G4R1 puriﬁed as described previously (50)
at concentrations of 10–120pM was incubated with 1pM
of 50-
32P-labeled G4 nucleic acid in RES–EDTA buffer
(100mM KCl, 10mM NaCl, 3mM MgCl2, 50mM Tris–
acetate, pH 7.8, 70mM glycine, 0.012% bovine
a-lactalbumin, 10% glycerol, 10mM EDTA) at 37 C for
30min. Binding mixtures were then analyzed by 10%
non-denaturing polyacrylamide gel. Electrophoresis was
performed at 70V for 10h in a cold room. Gels were
imaged on a Typhoon 9210 Imager (GE Healthcare).
The experiments determining the effect of ATP on
G4R1/YP-3 association were carried out as previously
described (61). An amount of 1 pM of 50-
32P-labeled
self-annealed YP-3 was incubated with different amounts
(25, 75 and 300pM) of G4R1 in the presence and absence
of 5mM ATP at 37 C for 30min. The samples were
analyzed on 10% non-denaturing polyacrylamide gel at
55V for 18h, followed by the same imaging procedure
described above.
Reporter assay
293 T cells cultured in 24-well plates were transfected with
200ng of the reporter constructs containing the YY1
promoter, 50-UTR or their mutant forms with altered se-
quences in the potential G4 structure-forming sequences,
and 2ng of a control plasmid pCMV/SEAP (secreted
alkaline phosphatase). To detect the effect of G4R1 on
the YY1 promoter or 50-UTR, 500ng of G4R1 expression
plasmid or empty vector was cotransfected with 200ng of
reporter plasmid and 2ng of pCMV-SEAP plasmid.
Aliquots of medium from the transfected wells were col-
lected 48h post-transfection to measure Gaussia luciferase
(Gluc) activity then normalized against the SEAP activity
in the same sample, according to the procedure described
by us (62). Each condition was tested in triplicate and
repeated over three times.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were per-
formed as previously reported (63). Samples immunopre-
cipitated by a control IgG, G4R1 antibody and histone
H3 antibody were analyzed with Real-Time PCR using the
FastStart Universal SYBR Green Master (Roche
Diagnostics GmbH) and the primers F5: ‘ccc gaa gcc
agg cga caa gaa c’ and R5: ‘gtg caa cag cca caa aac ccg’.
The F5 and R5 are located at the upstream ( 525) and
downstream ( 208) of the potential G4R1-binding site,
respectively, in the YY1 promoter. As a control, we also
designed two primers F6: ‘atg cta agg cca aaa aca acc agt
g’ and R6: ‘tga aac gag att aca gag caa gat a’ that are
located in the YY1 exon 5 (+1700 and+1948, respectively)
and amplify a fragment with relatively low G/C contents
(34.6% of G/C; 17.3% of each).
Microarray analysis of YY1 and G4R1 expression proﬁles
The Uppsala breast cancer cohort with the tumor samples
from 258 breast cancer patients (64) proﬁled on the
Affymetrix U133A and U133B GeneChips were accessed
via the caArray website (https://array.nci.nih.gov/
caarray/project/details.action?project.experiment.public
Identiﬁer=mille-00271), accession id: mille-00271. The
microarray data were MAS5.0 normalized by scaling the
mean of each array to a target signal intensity of 500 and
log (base 2) transformed. Multiple correlated probe sets
corresponding to YY1 and G4R1 (or DHX36) were
identiﬁed. Three YY1 probe sets (U133A: 213494_s_at,
201901_s_at and 200047_s_at) and three G4R1 probe
sets (U133B: 223138_s_at, 223139_s_at and 223140_s_at)
were averaged together to represent expression proﬁles of
YY1 and G4R1, respectively. The correlation of YY1 to
G4R1 expression was evaluated by Pearson correlation
using SigmaPlot 11.0 software.
Statistical analysis
All data in reporter assays and qPCR are presented as
mean±SD. Comparisons between two groups on a
single parameter were conducted using Student’s t-test.
Statistical analyses were performed using KaleidaGraph.
The criterion for statistical signiﬁcance was set at P<0.05.
RESULTS
The YY1 promoter and 50-UTR are highly G/C-rich and
contain potential G4 DNA and G4 RNA structure-
forming sequences, respectively
For a speciﬁc gene, G4 DNA structure can be formed by
either the positive or the negative strand of its promoter,
while G4 RNA structure in the 50-UTR will only be
present in the mRNA coded by the positive strand.
Thus, the G/C content in a promoter and G content in a
50-UTR are essential determinants to the formation of G4
DNA and G4 RNA motifs, respectively. A previous study
by Seto’s group demonstrated that the promoter region
within 1500-bp upstream of human YY1 transcription
start site did not show marked difference in reporter
assays compared to the fragment up to  3600bp (65).
Therefore, we ﬁrst analyzed the G/C contents in different
promoter regions from the YY1 transcription start site
(designated as +1) up to its 1500-bp upstream ( 1500),
and the 50-UTR of the YY1 mRNA. As shown in
Figure 1A, the G/C contents of the YY1 promoter
increase monotonically as the analyzed region gets closer
to the transcription start site. Remarkably, the G/C
1036 Nucleic Acids Research, 2012,Vol.40, No. 3content from  500 to  1i s>76.8%. The G/C content in
the YY1 50-UTR is 80.0%, with a G content of 44.4%,
markedly higher than the average of the four nucleotides.
These analyses clearly indicate that YY1 has great poten-
tial of containing G4 motifs in its promoter and 50-UTR
regions.
Since the G/C content from  1000 to  1 in the YY1
promoter is >67.3%, we chose to analyze this region for
potential G4 DNA structure-forming sequences based on
the algorithm proposed in previous literature (66). As a
result, we identiﬁed four elements (YP-1 to YP-4; YP:
YY1 Promoter) that may form G4 DNA structures on
either the positive strand (YP-1) or negative strand
(YP-2, -3 and -4) of the YY1 promoter (blue text in
Figure 1B). The analyses of the YY1 50-UTR also
revealed four candidate sequences (YU-1 to YU-4; YU:
YY1 50-UTR) for G4 RNA structure formation (red text
in Figure 1B).
Analyses of oligodeoxyribonucleotides derived from
the YY1 promoter and 50-UTR by CD spectroscopy
indicate the formation of G4 structures
To examine G4 DNA or RNA structure formation by the
candidate sequences in the YY1 promoter and 50-UTR
shown in Figure 1B, we designed oligodeoxyribonu-
cleotides based on either their original or complementary
sequences (Figure 2A). For the candidates in the YY1
50-UTR, we planned to use their sequences to make
oligodeoxyribonucleotides in this primary screening
analysis based on the structural similarity between G4
DNA and G4 RNA, and then conﬁrm the presence of
G4 RNA structure using the oligoribonucleotides. We in-
dividually annealed these oligonucleotides as described in
Supplementary Figure S1. As a control, we also
synthesized a sequence located in the human c-Myc
promoter that forms a well-characterized G4 DNA
Figure 1. Schematic primary structure and sequence of the YY1 promoter and 50-UTR. (A) Primary structure and the G/C contents of the YY1
promoter and 50-UTR. The percentages of G/C contents in the 1500bp-YY1 promoter and the 50-UTR, as well as the G content in the 50-UTR, are
indicated. The transcription start site is designated as ‘+1’. (B) The DNA sequence of the YY1 promoter (1000bp) and 50-UTR. The G4 DNA
candidates in the YY1 promoter, either the positive or negative strands, are in blue text, while the G4 RNA candidates in the YY1 50-UTR are in red
text. The promoter is shown in capital letters, while the 50-UTR is in lower case. YP-1, -2, -3 and -4 in the YY1 Promoter (YP) and YU-1, -2, -3 and
-4 in the YY1 50-UTR (YU) indicate the positions of the oligonucleotides shown in Figure 2A. The numbers in green text indicate the positions of
the ﬁrst nucleotides in these candidate G4 structure-forming sequences, which are identiﬁed by the dots beneath them. The underlined sequence in the
YY1 50-UTR is the overlapped region of YU-2 and YU-3. Neg: negative strand; Pos: positive strand.
Nucleic Acids Research,2012, Vol.40, No. 3 1037structure (c-Myc G4 DNA, Figure 2A) (67). These
annealed samples were then analyzed by CD spectroscopy.
In all CD studies, the annealed c-Myc G4 oligodeoxyr-
ibonucleotide displayed peaks of positive molar ellipticity
at 262nm and negative molar ellipticity at 240nm, which
is characteristic of a parallel G4 structure (68).
Oligodeoxyribonucleotides YP-3 and YU-4 displayed
peaks of positive molar ellipticity at 262nm (closed tri-
angles, Figure 2B), indicative of the presence of a
parallel G4 structure in this in vitro condition. However,
a second peak of positive molar ellipticity at 295nm was
also observed with both oligodeoxyribonucleotides, sug-
gesting the presence of a G4 structure with anti-parallel
strands. To conﬁrm that these signature peaks indicate G4
structure, we synthesized two control oligodeoxyribonu-
cleotides YP-3M and YU-4M, in which the guanines with
predicted roles in G4 structure formation of YP-3 and
YU-4 were replaced by adenines (Figure 2A). These
mutated oligonucleotides exhibited altered CD spectra
with a single peak not coincident with either the 262 or
295nm peaks observed with the wild-type oligodeoxyribo-
nucleotides (open triangles, Figure 2B). These results
indicate that the oligodeoxyribonucleotides YP-3 and
YU-4 form G4 structures with a mixture of parallel and
anti-parallel strands.
The spectra of the other three oligodeoxyribonu-
cleotides YP-1, YP-2 and YP-4 whose sequences are
found in the YY1 promoter gave no indication of G4
structure (Figure 2B). Among the other three oligodeox-
yribonucleotides whose sequences are located in the YY1
50-UTR, the CD spectra of YU-1 and YU-2, but not
YU-3, were similar to that of YU-4, although the peak
heights of the YU-2 spectrum were substantially dimin-
ished (Figure 2B), suggesting that these two oligodeoxyr-
ibonucleotides can also form G4 structures with a mixture
of parallel and anti-parallel strands.
DMS footprinting assays of YY1 G4 DNA structures
The YP-3 oligonucleotide contains 7–9 separate G-runs
(Figure 2A). To determine whether YP-3 forms intramo-
lecular or intermolecular structures, we carried out a stoi-
chiometry study. The labeled and unlabeled YP-3 and
YP-3-10A (YP-3 with 10 adenines added to its 30-end)
were mixed in different combinations and annealed in
the presence of 50mM KCl, followed by analysis in a
20% non-denaturing polyacrylamide gel. When YP-3
Figure 2. The CD and DMS footprinting to determine the G4 structure of the oligodeoxyribonucleotides. (A) The sequences of the oligonucleotides
for the candidate G4 structure-forming sequences located in the YY1 promoter and 50-UTR. The oligonucleotide sequences (Asterisk), their original
sequences (section symbol) when the potential G4 structures are present in the negative strand (for YP-2, -3 and -4) and their positions are indicated.
The guanines that likely contribute to the G4 structure formation are underlined. YP-3M and YU-4M contain the mutated nucleotides (underlined
and in reversed cases from the other bases in the same sequences) that are predicted to disrupt the potential G4 structures in YP-3 and YU-4,
respectively. The sequences of c-Myc G4 DNA (67), Zic-1 G4 DNA (73) and rAGA G4 RNA (50) have been previously reported. (B) CD analyses of
the oligodeoxyribonucleotides. The red dashed lines pointed to by the closed arrow heads indicate the signature peaks of parallel G4 structures at
262nm, while the blue dashed lines pointed to by the open arrow heads indicate the peaks of molar ellipticity after the G4 structure-forming
sequences were mutated. (C) DMS footprinting assay to conﬁrm the G4 DNA structure in YP-3. The 50-
32P-labeled oligodeoxyribonucleotide YP-3
was annealed under the conditions of no added cation (lane 1), in the presence of 100mM KCl (lane 2) or 100mM LiCl (lane 3) and then treated
with DMS. The result of formic acid treatment (Maxam-Gilbert G+A reaction) is shown on the left. The dashed lines align the bands with the YP-3
sequence, shown to the right. The markedly protected guanines in lane 2 compared to the other two lines are marked by arrow heads.
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(continued)and YP-3-10 A were annealed individually, each of them
exhibited a major band (lanes 1 and 2, Supplementary
Figure S2). When each of them was annealed in the
presence of the other oligonucleotide in either unlabeled
or labeled status, its major band did not show any shift
and no noticeable extra band was detected (lanes 3–7).
The oligonucleotides without annealing treatment also
showed two major bands migrating to the same positions
of their correspondingly annealed samples (lanes 8 and 9),
suggesting their instant and favorable transition to the
G4-containing structures. Overall, the results of this
stoichiometry study strongly suggested that the YP-3
oligonucleotide forms intramolecular, instead of intermo-
lecular, structures.
The guanine N7 in double- and single-stranded DNA is
available for methylation by DMS, while the N7 of the
guanines in a G4 structure is inaccessible due to the for-
mation of Hoogsteen hydrogen bonds. To conﬁrm the G4
DNA structure in the YY1 promoter and 50-UTR, we
determined DMS-accessibility of the guanine N7 in the
oligodeoxyribonucleotide YP1 to YP-4 and YU-1 to
YU-4 annealed in the absence and presence of 100mM
KCl or 100mM LiCl. Among these oligodeoxyribonu-
cleotides, the YP-3 exhibited the most pronounced sensi-
tivity changes to DMS-mediated methylation (Figure 2C
and Supplementary Figure S3). Compared to the condi-
tions of no extra cation and 100mM LiCl, most guanines
at the 50-end of the YP-3 in the presence of 100mM KCl
were markedly protected, indicating the presence of
Hoogsteen hydrogen bonds, as would be expected with
the formation of G4 DNA structures. This result is con-
sistent with the CD study, strongly indicating the presence
of G4 DNA structure in the YY1 promoter. Among other
YP-oligodeoxyribonucleotides, the YP-1 and YP-2, but
not YP-4, showed partial protection (Supplementary
Figure S3A). Since the DMS footprinting result of the
Figure 2. Continued.
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region for further studies. We also observed partial
(YU-4) or marginal (YU-1, -2 and -3) protection of the
YU-oligodeoxyribonucleotides to DMS-mediated methy-
lation (Supplementary Figure S3B). However, as an
example of a G4 structure located in the YY1 50-UTR,
we only focused on YU-4 for further investigation.
The strong monovalent cation dependence of the formation
of secondary structure by oligodeoxyribonucleotide YP-3
and oligoribonucleotide YU-4 conﬁrms the presence
of G4 DNA structures
It is known that the formation of G4 structure is stabilized
by potassium, but disfavored by lithium ions (69).
Therefore, to conﬁrm that oligodeoxyribonucleotide
YP-3 and oligoribonucleotide YU-4 self-anneal into G4
structures, we determined the effects of the monovalent
cationic environment on the G4 structure formation and
thermal stability of the secondary structure formed by
these ribonucleotides. We annealed oligodeoxyribo-
nucleotide YP-3 and oligoribonucleotide YU-4 in the
absence and presence of 50mM KCl or 50mM LiCl,
and then carried out CD analyses, again using c-Myc
G4 DNA as a control. As shown in the top panels of
Figure 3A and B, both wild-type oligodeoxyribo-
nucleotide YP-3 and oligoribonucleotide YU-4, similar
to the c-Myc G4 DNA, exhibited peaks of positive
molar ellipticity at 262nm and negative molar ellipticity
at 240nm when annealed in 50mM KCl. Both the positive
and negative peaks of molar ellipticity were markedly di-
minished when the YP-3 and YU-4 were annealed in
50mM LiCl, or in a buffer containing no additional
monovalent cation. The CD spectra of self-annealed
oligodeoxyribonucleotide YP-3M and oligoribonucleotide
YU-4M that contain mutated nucleotides in the G4 se-
quences displayed small peaks of positive and negative
molar ellipticity at 262 and 240nm, respectively, but
these peaks displayed no dependence on the local mono-
valent cation environment (bottom panels in Figure 3A
and B). These spectra are consistent with the formation
of parallel G4 DNA and RNA structures, respectively, by
oligodeoxyribonucleotide YP-3 and oligoribonucleotide
YU-4. It is noteworthy that the spectrum of the oligoribo-
nucleotide YU-4 contains no evidence of an anti-parallel
G4 structure. This is because the 30-endo pucker of ribose
in RNA is known to cause a prohibitively high energy cost
to the anti-syn rotation necessary for anti-parallel G4
structure formation (70,71).
Marked monovalent cation dependence of the
thermal stability of secondary structure by
oligodeoxyribonucleotide YP-3 and oligoribonucleotide
YU-4 conﬁrms the presence of G4 structures
G4 nucleic acids are thermostable structures. Therefore,
DNA or RNA sequences with potential of forming G4
structures typically show high melting temperatures
(Tms). To further conﬁrm the G4 structures in the
oligodeoxyribonucleotide YP-3 and oligoribonucleotide
YU-4, we determined the temperature dependence of the
positive peak of molar ellipticity at 262nm for these two
oligonucleotides and their mutants annealed in the
presence of 50mM KCl, 50mM LiCl, or no additional
monovalent cation in the temperature range from 20 C
to 94 C. As shown in the top panels of Figure 3C and
D, wild-type oligodeoxyribonucleotide YP-3 and
oligoribonucleotide YU-4 clearly showed higher thermal
stability when annealed in the presence of 50mM KCl
with Tms of 86 C and 81 C, respectively (estimated as
the temperature at which the molar ellipticity had been
reduced by 50%), than those when annealed in 50mM
LiCl or no additional monovalent cation. Both mutant
oligodeoxyribonucleotide YP-3M and oligoribonucleotide
YU-4M exhibited decreased Tms (53 C and 52 C, respect-
ively, when annealed in the presence of 50mM KCl) in
comparison with the wild-type oligonucleotides, and
reduced dependence of the melting curves on the local
cationic environment (bottom panels of Figure 3C and
D). These thermal stability data are consistent with the
CD spectral results shown above in supporting the
hypothesis that oligodeoxyribonucleotide YP-3 self-
anneals in the presence of 50mM KCl into a mixture of
parallel and anti-parallel G4 DNA structures, and that
oligoribonucleotide YU-4 self-anneals into a parallel G4
RNA structure.
In vitro footprinting of the YY1 promoter region with
DNase I
DNase I preferentially cleaves locally unwound or normal
duplex DNA regions versus single-stranded regions or sec-
ondary structures (72). When a supercoiled pGL3/
YY1-short-prmt plasmid was incubated with 100mM
KCl and digested with DNase I, the primer extension
reaction indicated a protected region approximately
from  329 to  440 of the YY1 promoter, including the
YP-3 sequence ( 409 to  347), versus the condition
without KCl addition (Figure 4, compare the two lanes
at right). This result suggested a possible transition from
B-DNA to a G-4 structure in the YY1 promoter region,
which provided resistance to DNase I digestion, as previ-
ously demonstrated by Sun (60).
G4 structure-forming sequences present in the YY1
promoter and 50-UTR modulate the expression
of a reporter gene
As we observed the presence of the sequences with the
potential of forming G4 structures in the promoter and
50-UTR of YY1, we asked whether these structures may
affect the expression of YY1. To answer this question, we
ﬁrst carried out reporter assays. As shown in Figure 5A,
we generated ﬁve reporter constructs (see ‘Materials and
Methods’ section for details). The constructs (a) and (b)
employ the wild-type and the G4 structure-mutated YY1
promoters ( 1703 to  1), respectively, to drive Gluc ex-
pression. The constructs (c) and (d) have the wild-type and
the G4 structure-mutated YY1 50-UTR sequences (+1 to
+480) inserted between the PGK promoter and Gluc
cDNA of an original reporter vector shown as (e) of
Figure 5A. Reporter assays conducted in 293 T cells
using the reporter plasmids (a) and (b) of the YY1
1040 Nucleic Acids Research, 2012,Vol.40, No. 3promoter demonstrated that mutations of the nucleotides
essential to G4 structure formation resulted in increased
YY1 promoter activity (1.5-fold or 54% increase,
P=0.01, Figure 5B), suggesting an inhibitory role of
the G4 motif in the YY1 promoter. The reporter assays
using the plasmids (c) and (d) indicated that the mutation
of the G4 structure in the YY1 50-UTR could also
promote the expression of the downstream Gluc
(Figure 5C). We noticed that the empty vector (e) ex-
hibited even higher expression than these two constructs
Figure 3. CD analyses of self-annealed oligodeoxyribonucleotide YP-3 or oligoribonucleotide YU-4 corresponding to sequences in the YY1
promoter and 50-UTR, respectively. (A and B). Wavelength scan of (A) oligodeoxyribonucleotide YP-3 and (B) oligoribonucleotide YU-4
annealed in different monovalent cationic environments. (C and D). Thermal stability analyses of the secondary structure formed in self-annealed
oligodeoxyribonucleotides or oligoribonucleotides corresponding to the sequences in the YY1 promoter and 50-UTR, respectively. The molar ellip-
ticity at 262nm of the annealed oligonucleotides in different monovalent cationic environments was observed at different temperatures. The poly-
nomial ﬁtting curve of each raw data set is shown as a dished curve with the Tm indicated by a dropped dashed line in the same color.
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50-UTR sequences, respectively. This could result from
either the difference of the distance between the
promoter and Gluc cDNA in these vectors, or the effects
of other secondary structures in the inserted DNA frag-
ments. Therefore, we normalized the Gluc activity of (c)
and (d) by that of the vector alone (e) in Figure 5C. After
this calculation, we observed that the G4 structure muta-
tions in the YY1 50-UTR led to a markedly increased ex-
pression of the downstream Gluc (2.4-fold or 142%
increase, P=0.001, Figure 5D).
The G4 nucleic acid resolvase G4R1 enhances reporter
gene expression driven by the YY1 promoter but
not the YY1 50-UTR
Several helicases have been reported to resolve G4 struc-
ture (45,47). Among them, G4R1 possesses the capability
of resolving both G4 DNA and G4 RNA motifs (50). To
explore the mechanisms underlying the regulation of the
G4 structures in the YY1 promoter and 50-UTR, we
carried out reporter assays to study the effects of G4R1
on these ﬁve reporter constructs described in Figure 5A.
When G4R1 was cotransfected with the reporter plasmid
(a), we detected an increased Gluc expression, compared
to the sample transfected with an empty vector (1.5-fold or
45% increase, P=0.01, columns 1 and 2 in Figure 6A).
The YY1 promoter containing a mutated G4 sequence
retained the response to ectopic G4R1 by an increased
transcriptional activity (1.3-fold or 32% increase,
P=0.003, columns 3 and 4 in Figure 6A). This suggests
that a concealed G4 motif(s) may exist in the YY1
promoter in addition to the one that we have identiﬁed.
We carried out experiments to test the effects of G4R1
on the YY1 50-UTR-mediated expression. Both reporter
constructs (c) and (d) containing the wild-type and G4
structure-mutated YY1 50-UTR, respectively, could be
stimulated by the transfected G4R1 (columns 5–8 in
Figure 6B). However, the transcriptional activity of the
PGK-Gluc vector without the YY1 50-UTR insert could
also be enhanced by the ectopic G4R1, indicating that the
PGK promoter is also responsive to G4R1. We therefore
normalized the data of columns 5–8 by the corresponding
Gluc expression of the vector controls (columns 9 and 10).
After this normalization, the relative expression of the
reporter constructs with either wild-type or the G4
motif-mutated YY1 50-UTR displayed very similar
activity in the absence and presence of ectopic G4R1
(9.2% increase, P=0.49, between columns 11 and 12;
4.2% decrease, P=0.33, between columns 13 and 14;
Figure 6C). These results indicate that the G4 sequence
motif in the YY1 50-UTR is unlikely a substrate of G4R1.
It is noteworthy that the reporter construct with the
mutated G4 structure still exhibited increased Gluc ex-
pression compared to the one with wild-type sequence
(compare columns 13, 14 with 11, 12, Figure 6C), consist-
ent with the observation in Figure 5D.
In vitro determination of the interaction and resolving
activity of G4R1 on the YY1 G4 structures
As we have demonstrated the stimulatory effect of G4R1
on the YY1 promoter, we further studied the binding
afﬁnity of G4R1 to the G4 DNA sequence in the YY1
promoter in vitro. We carried out the electrophoretic
mobility shift assay (EMSA) using recombinant G4R1
protein puriﬁed as previously described (55) and the
32P-labeled oligodeoxyribonucleotide YP-3 or its
mutated form YP-3M (Figure 2A). When
32P-labeled
YP-3 was incubated with increasing amounts of G4R1,
slowly migrating bands with generally escalating intensity
(compare lane 1 with lanes 2–6 in Figure 7A) were
observed, which is likely the complex formed by the
G4R1 and oligodeoxyribonucleotide YP-3. However,
Figure 4. In vitro footprinting of the YY1 promoter region with DNase
I. DNA sequencing and primer extension reactions were carried out as
described in the ‘Materials and Methods’ section. The nucleotide
numbers for the region resistant to DNase I digestion ( 440 to
 329) and the region of the YP-3 ( 409 to  347) are marked on the
left. The YP-3 region and the directions of the YY1 promoter and
DNA sequencing are indicated on the right. The annotation
(C,T,A,G) of DNA sequencing reaction for plasmid pGL3/
YY1-short-prmt is according to the positive strand of the YY1
promoter. The primer extension of the same plasmid was conducted
in the absence ( ) and presence (+) of 100mM KCl.
1042 Nucleic Acids Research, 2012,Vol.40, No. 3Figure 5. Reporter assay to study the effects of mutating potential G4 structure-forming sequences in the YY1 promoter and 50-UTR on gene
expression. (A) Schematic diagrams of the constructs generated for reporter assays. Constructs (a) and (b) employ the 1703bp YY1 promoter to drive
Gluc expression. Gluc expression in constructs (c), (d) and (e) was driven by the PGK promoter. Wild-type or mutated YY1 50-UTR is inserted
between the PGK promoter and Gluc cDNA in (c) and (d), respectively. The guanines with potential of forming G4 structures are underlined. The
mutated guanines and the replacing bases are underneath labeled by dots. The introduced SphI and KpnI sites are indicated. Gluc, Gaussia
luciferase; PGK, phosphoglycerate kinase. The mutated sites that altered the G4 structure-forming sequences are indicated as shadowed bars in
the YY1 promoter and 50-UTR. (B and C) Gluc activity of the reporter constructs containing the wild-type and mutated (B) YY1 promoter and (C)
50-UTR sequences, respectively. (D) Normalized Gluc activity of the data in ‘C’. Asterisk indicates signiﬁcant changes.
Figure 6. Effects of G4R1 on the expression mediated by the YY1 promoter and 50-UTR. (A and B) Effects of G4R1 on Gluc expression mediated
by (A) the YY1 promoter and (B) YY1 50-UTR. In ‘A’, G4R1-expressing plasmid or the empty vector (500ng) was cotransfected with either the
reporter construct (a) containing wild-type YY1 promoter sequence, or (b) with mutated YY1 promoter sequence (200ng, Figure 5A) in 24-well
plate. In ‘B’, G4R1-expressing plasmid or the empty vector (500ng) was individually cotransfected with the reporter constructs (c), (d) and (e)
(200ng). The ectopically expressed G4R1 with b-actin as loading controls was examined by western blots shown under the graphs. (C) Normalized
Gluc activity of ‘B’. Asterisk indicates signiﬁcant changes.
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structure sequence failed to show any complex formation
at the same conditions (lanes 7–12 in Figure 7A). In this
study, we used a unimolecular G4 structure formed by
self-annealing of an oligodeoxyribonucleotide whose
sequence corresponds to the Zic-1 G4 DNA ﬂanked by
10 adenines at each end (PolyA Zic-1 G4 DNA,
see Figure 2A) (73) as a positive control (lane 13,
Figure 7A), as we observed that PolyA Zic-1 G4 DNA
efﬁciently associates with G4R1 (52). These results
indicate that G4R1 can speciﬁcally bind to the G4 motif
in the YY1 promoter. It is noteworthy that the free
32P-labeled YP-3 migrated faster than the free
32P-labeled YP-3M, suggesting that the G4 motif made
oligodeoxyribonucleotide YP-3 more compact and there-
fore faster migrating than the YP-3M with disrupted G4
structure.
We also assessed the binding afﬁnity of G4R1 to the G4
structure of the oligoribonucleotide whose sequence is
found in the YY1 50-UTR. While the incubation of
G4R1 with rAGA (Figure 2A), a G4-RNA that was pre-
viously demonstrated to associate with G4R1 (50),
caused the appearance of a slowly migrated band (lane
15, Figure 7B), neither oligoribonucleotide YU-4 nor
YU-4M showed any interaction with G4R1 (lanes 1–14).
To determine whether G4R1 resolves or stabilizes the
G4 DNA structure in the YY1 promoter, we studied the
G4R1 and YP-3 association in the presence and absence
of ATP. In the presence of ATP, which is required for the
resolvase activity of G4R1, we detected both G4R1/YP-3
complex and free YP-3 in comparison to the control with
only annealed YP-3 (Figure 7C, lanes 2–4 versus lane 1).
However, in the absence of ATP, the G4R1/YP-3 associ-
ation was markedly increased, while the detected free
YP-3 was largely reduced (lanes 5–7). This result
suggests that G4R1 binds YP-3 tightly in the absence of
ATP, but resolves and then releases YP-3 when ATP is
provided. The binding, resolving and refolding are rapid
and dynamic. Therefore, the free YP-3 could very quickly
transform back to the favored compact G4 structures after
being resolved by G4R1 and therefore the slowly
migrated, unstructured YP-3 was not observed in the
lanes 2–4 of Figure 7C.
G4R1 binds the YY1 promoter and its manipulated
expression affects endogenous YY1 levels
As we observed the association of G4R1 and oligodeox-
yribonucleotide YP-3 in vitro, we asked whether G4R1
binds the YY1 promoter in cells. Therefore, we carried
out ChIP assays with the anti-G4R1 antibody, using
non-speciﬁc IgG (sc-2343) as a negative control and
histone H3 antibody as a positive control. As shown in
the top panel of Figure 8A, G4R1 exhibited  5-fold
higher binding afﬁnity than the control sample
(P=0.004), implicating that G4R1 directly regulates
YY1 gene expression. As a positive control, the histone
H3 antibody showed stronger signal than the G4R1
Figure 7. EMSA to study the interaction and resolvase activity of G4R1 to the YY1 G4 structures. (A) EMSA study to determine the interaction
between G4R1 and oligodeoxyribonucleotide YP-3. An amount of 1pM of 50-
32P-labeled self-annealed YP-3 (lanes 1–6) and YP-3M (lanes 7–12)
were incubated with increasing amounts of puriﬁed G4R1 (10–120pM), as indicated on the top. An amount of 1pM of 50-
32P-labeled self-annealed
PolyA Zic-1 oligodeoxyribonucleotide was used as a positive control. The position of G4R1–DNA complexes and the unbound 50-
32P labeled
oligodeoxyribonucleotides (or probes) are denoted on the left. (B) EMSA study to detect the interaction between G4R1 and oligoribonucleotide
YU-4. Same as ‘A’, 50-
32P-labeled self-annealed YU-4 (lanes 1–7) and YU-4M (lanes 8–14) were incubated with increasing amounts of puriﬁed G4R1
as indicated. An amount of 1 pM of 50-
32P-labeled self-annealed rAGA was used as a positive control. (C) Gel mobility shift assay to detect
ATP-dependency of G4R1/YP-3 association. An amount of 1 pM of 50-
32P-labeled self-annealed YP-3 was incubated with increasing amounts (0, 25,
75 and 300pM) of G4R1 in the presence and absence of 5mM ATP. The samples were resolved by 10% non-denaturing polyacrylamide gel. The
G4R1/YP-3 complexes and free YP-3 oligodeoxyribonucleotide are indicated.
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antibody, we also ampliﬁed a region in the YY1 exon 5
that has relatively low G/C content (17.3% of either G or
C). As presented in the bottom panel of Figure 8A, only
histone H3 antibody showed high binding afﬁnity to this
region, while G4R1 antibody exhibited comparable signal
to the negative control antibody.
Since G4R1 binds to the YY1 promoter and stimulates
its activity in driving Gluc expression in the reporter
assays, we asked whether G4R1 affects the expression of
endogenous YY1. We ﬁrst transiently transfected
increasing amounts of G4R1 into 293T cells, as they
express relatively low levels of G4R1, and determined
the endogenous YY1 levels by western blot. As shown in
Figure 8B, YY1 expression was elevated with increasingly
expressed G4R1. To determine whether G4R1 is required
in maintaining endogenous YY1 expression, we inducibly
knocked down G4R1 in HeLa cells that express high levels
of G4R1. As shown in Figure 8C, the depletion of G4R1
only slightly reduced the levels of endogenous YY1, sug-
gesting that G4R1 may not play a crucial role in main-
taining YY1 expression.
G4R1 expression generally correlates with YY1
expression in breast cancer samples
As ectopic G4R1 affects endogenous YY1, we proceeded
to determine whether there is any correlation between the
expression levels of these two proteins. First, we took
breast cancer as an example to test G4R1 and YY1 ex-
pression in some commonly used cell lines with normal
human mammary epithelial cells (HMEC) as controls.
We also included MCF-10A cells that are non-
tumorigenic but immortalized. The tumorigenic cell lines
included HEK (HMEC immortalized by SV40 large-T
antigen, the telomerase catalytic subunit and an H-Ras)
(74), SK-BR-3, ZR-75-1, BT-474 and MDA-MB-231. We
analyzed an equal amount of cell lysates from these breast
cell lines by western blot using antibodies for G4R1, YY1
(H-10) and b-actin. As shown in Figure 9A,
non-tumorigenic MCF-10A cells and all tumor cell lines,
except BT-474, expressed elevated G4R1 expression
compared to HMEC, while YY1 levels are markedly
increased in all tumor cell lines compared to MCF-10A
and HMEC. These results suggest that both G4R1 and
YY1 are overexpressed in most breast cancer cells. To
determine whether G4R1 expression correlates with YY1
levels in primary human breast cancer, we analyzed a set
of Affymetrix microarray expression proﬁles derived from
the Uppsala breast cancer cohort consisting of 258 patient
samples (64) using the probes indicated in the ‘Materials
and Methods’ section. As shown in Figure 9B, the gene
expression patterns of G4R1 and YY1 in these 258 breast
tumors exhibited a signiﬁcant correlation (P=4.5 10
 6,
Pearson correlation), which is consistent with the results
obtained from our in vitro studies.
Figure 8. ChIP assay of G4R1 afﬁnity to the YY1 promoter and effects of altered G4R1 expression on endogenous YY1 levels. (A) ChIP assay of
the YY1 promoter. Non-speciﬁc mouse IgG (control), G4R1 antibody and histone H3 antibody were used in the immunoprecipitation. The ampliﬁed
regions aligned to the YY1 promoter and mRNA (with transcription starting site designated as ‘+1’) are indicated. The amounts of the YY1 DNA
precipitated by these antibodies relative to the input are presented. The results are derived from three separate experiments. Asterisk indicates
signiﬁcant changes. (B) Effect of ectopic G4R1 on endogenous YY1 expression in 293 T cells. Increasing amounts of G4R1, as shown above the blot,
were transfected into 293 T cells that expressing relatively low levels of endogenous G4R1. The cell lysates were analyzed by western blots using the
antibodies indicated on the left. (C) Effects of G4R1 knockdown on endogenous YY1 expression in HeLa cells. HeLa cells that express high levels of
endogenous G4R1 were infected by lentivirus expressing an inducible shRNA against G4R1 (54) cultured in medium containing 1.5mg/ml of
doxycycline (Dox) to induce the shRNA expression. The cells were collected at different time points as indicated on the top and the cell lysates
were analyzed by western blots using the antibodies indicated on the left.
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The regulatory activities of YY1 in different epigenetic
processes have implicated its critical role in cell prolifer-
ation, differentiation and tumorigenesis. As a multifunc-
tional transcription factor, YY1 has been extensively
studied in its regulation towards the expression of
various target genes. However, the mechanisms
underlying how YY1 gene expression is regulated are rela-
tively understudied. In this report, we revealed the G/C
rich features in the vicinity of the YY1 transcription start
site on the human YY1 promoter and 50-UTR. We then
provided clear in vitro evidence to demonstrate that these
regions contain sequences capable of forming G4 DNA
and RNA structures, respectively, and that mutations of
these G4 structure-forming sequences affected the YY1
promoter-mediated Gluc expression or that downstream
of the YY1 50-UTR in reporter assays. Our mechanistic
studies also suggested that the G4 nucleic acid resolvase
G4R1 may release the G4 structure in the YY1 promoter,
but not the one in the YY1 50-UTR. To investigate the
biological relevance of our study, we also analyzed the
gene array of 258 human breast cancer samples and dis-
covered the signiﬁcant correlation between G4R1 and
YY1 gene expression.
In the promoter region, G4 DNA structures that
regulate the gene expression may exist in either the
positive or negative strand. It is noteworthy that
cytosine rich (C-rich) DNA sequences may form i-motifs
that have been indicated to regulate the expression of
multiple genes, including Bcl-2 and c-Myc (75,76).
Therefore, it is reasonable to predict that, while G4
motifs are present in one strand, structures such as
i-motifs can also be formed in the Watson–Crick comple-
mentary strand. They may collaboratively regulate the
transcriptional activity of the YY1 promoter, as described
in a model for the c-Myc promoter (40).
The YY1 promoter likely forms multiple G4 structures
due to its high G/C content and it is not practical for us to
determine all of them in this study. However, our results
strongly indicated the presence and regulatory role of the
G4 structure in the YY1 promoter. In the YP-3 oligo-
nucleotide, there are 7–9 isolated G-runs ( 3 Gs) and
our stoichiometry experiment suggested the majority of
this oligonucleotide formed intramolecular structures.
Therefore, we predict that the YP-3 oligonucleotide
forms multiple, dynamic G4 structures among these
G-runs that may rapidly interchange, leading to the pro-
tection of multiple guanines in the DMS footprinting
assay (Figure 2C). Consistently, our CD studies also sug-
gested the presence of G4 structures with anti-parallel
strands in the YP-3 (Figure 2B). The dynamic G4 struc-
ture formation has been demonstrated previously (77,78),
which makes it technically challenging to create a sche-
matic picture to present the predicted G4 structures and
would be beyond the scope of this current study.
We demonstrated an interaction of G4R1 with the G4
sequence motif in the YY1 promoter, as well as a stimu-
latory effect of G4R1 on the expression driven by the YY1
promoter. However, we also observed that G4R1 could
still enhance the expression of the reporter construct
driven by the G4 structure-mutated YY1 promoter, as
shown in Figure 6A. Since the region close to the tran-
scription start site in the YY1 promoter is highly G/C rich,
this effect could result from other G4 DNA structure(s)
that has not been identiﬁed. It is also possible that the
activity of the YY1 promoter is inhibited by other types
of structures, which can be resolved by G4R1.
In the EMSA studies, we did not detect large amounts
of unbound oligonucleotides (Figure 7), since only 1pM
of 50-
32P-labeled self-annealed YP-3 oligonucleotide was
incubated with 10–300pM of G4R1. The reason to use
this ratio is that these concentrations represent standard
binding afﬁnity determination conditions. When
determining the binding afﬁnity of an annealed oligo-
nucleotide, it is important that the oligonucleotide is
used at a much lower concentration than that of the
resolvase. Given the extraordinarily tight binding afﬁnity
of G4R1 for G4 nucleic acids (52), the concentration of
the G4 oligonucleotides should be kept close to 1pM. As
shown in Figure 7C, G4R1 tightly bound YP-3 in the
absence of ATP. This binding interaction at low YP-3
concentrations is strongly indicative of the presence of
G4 structures in YP-3, as G4R1 prefers to bind G4
nucleic acids in comparison to unstructured single
stranded DNA or Watson-Crick duplex DNA by at
least 3 orders of magnitude (50,55). YP-3 was released
from the G4R1 after resolution of the G4 structure
when ATP was added (52). This result strongly suggests
Figure 9. Studies of G4R1 and YY1 expression in breast cancer cell
lines and patient samples. (A) G4R1 and YY1 expression in different
non-malignant and malignant breast cell lines. Total cell lysates of the
cell lines (labeled on the top) were analyzed by western blot (antibodies
labeled on the left). HMEC and MCF-10A were used as non-malignant
controls. HEK cells are a breast cancer cell line immortalized by SV40
large-T antigen (74). (B) Analysis of the expression correlation between
G4R1 and YY1 in breast cancer samples in the Uppsala breast cancer
cohort consisting of 258 patient samples. The signal intensities of G4R1
and YY1 were logarithmically transformed. A signiﬁcant, positive cor-
relation is suggested by the Pearson Product Moment Correlation
P-value of 4.5 10
6.
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oligonucleotide.
When testing the effects of the YY1 50-UTR on the ex-
pression of downstream Gluc, we employed the PGK
promoter. In our study, we observed that this promoter
can be stimulated by G4R1, suggesting that it may
contain G4 DNA structure motif(s). It is certainly
possible that G4R1 possesses other activities, in addition
to resolving G4 structures, which may generally promote
gene expression. After examining the DNA sequence, we
found that this promoter is indeed G/C rich (>63%) and
has multiple G- or C-runs. We also checked several other
commonly used promoters with medium expression
strengths, including chicken b-actin and ubiquitin C pro-
moters. They both have high G/C contents and potential
G4 DNA-forming sequences. CMV promoter has nearly
equal amounts between G/C and A/T, but its robust ex-
pression strength could overwhelm the effect of G4R1 on
any putative G4 structure. Therefore, we still used the
PGK promoter to study the YY1 50-UTR-mediated ex-
pression and compensated the effects of G4R1 by
normalizing the data against those of the reporter
construct without the YY1 50-UTR insert. After this data
processing, we concluded that the YY1 50-UTR-mediated
Gluc expression was unresponsive to the ectopically
introduced G4R1. Consistently, G4R1 did not bind to
oligoribonucleotide YU-4 in our EMSA study
(Figure 7B). Whether the G4 RNA motif in the YY1
50-UTR is a substrate of other resolvases, such as BLM,
WRN, or FANCJ, needs further investigation. It is likely
that multiple G4 structures may exist in the 480-nt YY1
50-UTR with such a high G content (44.4%), a speculation
that is supported by the CD studies of the oligonucleotides
YU-1 and YU-2 (Figure 2B). However, we believe that
G4R1 does not bind these two oligonucleotides, since the
expression of the reporter construct containing the entire
50-UTR region of YY1 was not affected by ectopic G4R1.
While G4R1 may possess general stimulatory effects on
gene expression, especially oncogenes that have G4 struc-
tures in their promoters, our data from the CD spectral
study, reporter assay and correlated G4R1-YY1 gene ex-
pression strongly suggest that YY1 is one of G4R1 target
genes and this regulation may contribute to cancer develop-
ment. It is noteworthy that G4R1 knockdown did not
markedly affect endogenous YY1 levels, although
ectopically expressed G4R1 led to an increased YY1 expres-
sion (Figure 8B and C). This indicates that YY1 expression
is modulated by multiple regulatory mechanisms, in addition
to G4 DNA/G4R1. Based on our data, G4R1 likely plays a
role in promoting, but not maintaining, YY1 expression.
The sequences of the G4 structures may contain or
overlap with the binding sites of certain transcription
factors. Thus, it is possible that the mutagenesis of the
guanines essential to G4 structure formation in the YY1
promoter could alter the afﬁnity of certain transcription
factor(s), likely repressor(s), and in turn enhance the
promoter activity in reporter assays. This dilemma is a
generic issue in the ﬁeld of G4 structure research. In our
studies, in addition to the data from reporter assays that
demonstrated the effects of G4 DNA-forming sequence
and G4R1 on the YY1 promoter-mediated gene
expression, we also presented spectroscopic evidence
from CD analyses and protection of the YY1 G4 DNA
structure from DMS-mediated methylation and DNase I
digestion. All data sets support the presence and the regu-
latory role of G4 structure in the YY1 promoter.
Numerous reports demonstrated the potential regula-
tion of YY1 in tumorigenesis. Although most studies
suggest an oncogenic or proliferative role of YY1 in
cancer development and progression [see the review (3)],
a handful reports also proposed the possible anti-cancer
activities of YY1 (10,79–81). Statistical analysis indicates
that G4 structures are present in the promoters of most
proto-oncogenes, while the promoters of tumor suppres-
sors have very low levels of guanine runs (43). Therefore,
our current study showing the G/C rich feature and the
presence of quadruplex in the YY1 promoter supports the
theory of YY1 as an oncogene.
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